InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million

Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time

YOKNEAM, Israel, Oct. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2024 before the Nasdaq market opens on Wednesday, October 30, 2024.

InMode is currently finalizing its financial results for the third quarter of 2024. While complete financial information and operating data are not yet available, set forth below are certain preliminary financial results for the period, subject to final adjustments and other developments that may arise between now and the time such financial results are published.

Regarding the current situation in Israel, InMode is prioritizing the safety and well-being of its employees, sub-contractors, and all its team members, who are safe. InMode is proactively assessing the relocation of certain production activities outside of Israel.

As previously discussed at the beginning of this year, InMode introduced two new platforms to the market, resulting in a transition phase with pre-orders received during the first half of this year. Management is happy to report that, by the end of the third quarter, InMode was able to fulfil all pre-orders and become current with all deliveries of incoming orders. This resulted in recognition during the third quarter of approximately $31.9 million of revenues that were previously deferred. Additionally, management continues to see macro-economic factors impacting the aesthetics industry. ...